Centre for Drug Research and Development

Project Funding Partners

Pfizer-CDRD Innovation Fund

Pfizer Canada has provided $3 million to the Centre for Drug Research and Development to launch a fund aimed at accelerating the commercialization of some of BC’s most promising academic research projects into high-value medicines that form the basis for new companies or licensing opportunities. This fund leverages an additional $1 million for innovation projects from the NCE Centres of Excellence in Commercialization and Research, bringing total CDRD Innovation project funding to $4 million.

The fund is administered by CDRD based on the recommendations of an expert review panel and is aimed at helping researchers overcome the costly gap between discovery and commercialization.

Genome BC–CDRD Development Fund

The Genome BC–CDRD Development Fund was created to accelerate the development of commercially promising projects related to advances and discoveries stemming from genome sciences and genetics. Genome BC has earmarked $1 million toward the fund on a project-by-project basis. CDRD will contribute up to $1 million in expertise, facilities, and equipment time.